TACOMA, WA - Federal health inspectors identified 11 deficiencies at Avamere Transitional Care of Puget Sound during a standard health inspection completed on November 25, 2025, including a notable failure in pharmacy oversight that left residents exposed to potential medication-related harm.
Monthly Medication Reviews Not Conducted as Required
Among the deficiencies documented, inspectors flagged the facility under regulatory tag F0756 for failing to ensure that a licensed pharmacist carried out monthly drug regimen reviews as mandated by federal regulations. These reviews are a fundamental safeguard in long-term care settings, requiring a pharmacist to examine each resident's complete medical chart and medication orders on a regular cycle.
The citation specifically noted that the facility did not maintain compliance with its own developed policies and procedures for reporting irregularities discovered during these reviews. Federal regulations require that when a pharmacist identifies a medication irregularity — such as a potential drug interaction, an unnecessary medication, or an incorrect dosage — the finding must be reported to the attending physician and the facility's director of nursing.
The deficiency was classified at Scope/Severity Level D, meaning it represented an isolated incident where no actual harm occurred but where there was potential for more than minimal harm to residents. While this is not the most severe classification available, pharmacy oversight failures carry significant clinical implications.
Why Drug Regimen Reviews Are Critical
Monthly drug regimen reviews exist because nursing home residents are among the most medically vulnerable populations in healthcare. The average long-term care resident takes seven to eight medications simultaneously, and many take considerably more. Each additional medication increases the risk of adverse drug interactions, side effects, and prescribing errors.
A pharmacist conducting a proper monthly review examines whether each medication remains necessary, whether dosages are appropriate given the resident's current condition, and whether any combinations could cause harmful interactions. Without this review, residents may continue receiving medications they no longer need, remain on dosages that should be adjusted, or face undetected drug interactions that can lead to falls, confusion, excessive sedation, gastrointestinal bleeding, or other serious complications.
For elderly residents with declining kidney or liver function, the stakes are particularly high. These organs are responsible for metabolizing and clearing medications from the body. As their function diminishes — a normal part of aging — drug concentrations in the bloodstream can reach dangerous levels if dosages are not regularly reassessed.
Eleven Total Deficiencies Raise Broader Questions
The pharmacy review failure was one component of a broader pattern identified during the inspection. With 11 total deficiencies cited across the facility, the inspection results suggest systemic compliance gaps that extend beyond a single department.
Federal nursing home inspections evaluate facilities across multiple domains, including quality of care, resident rights, infection control, staffing, and administrative practices. When a facility accumulates a substantial number of citations in a single survey cycle, it often indicates that underlying operational or management issues are affecting multiple areas of resident care.
The facility reported that it had already implemented corrections as of October 30, 2025 — notably, a date that preceded the inspection itself. This timeline suggests that the facility may have identified and begun addressing some issues independently before inspectors arrived, though the deficiencies were still formally documented during the survey.
Federal Standards for Pharmacy Oversight
Under the Code of Federal Regulations (42 CFR § 483.45), every Medicare- and Medicaid-certified nursing facility must maintain pharmaceutical services that meet the needs of each resident. This includes employing or contracting with a licensed pharmacist who reviews each resident's drug regimen at least once per month and reports any irregularities to the medical director and administrator.
Facilities are expected to develop written policies governing how these reviews are conducted, how irregularities are documented, and what follow-up actions are required when problems are identified. The citation at Avamere Transitional Care indicated a breakdown in adherence to these established protocols.
Residents and families seeking complete details about all 11 deficiencies identified during this inspection can review the full survey results through the Centers for Medicare & Medicaid Services Care Compare database, which provides public access to inspection histories for every certified nursing facility in the United States.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avamere Transitional Care of Puget Sound from 2025-11-25 including all violations, facility responses, and corrective action plans.